Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise is currently trading at Rs. 898.90, up by 11.25 points or 1.27 % from its previous closing of Rs. 887.65 on the BSE.

The scrip opened at Rs. 886.00 and has touched a high and low of Rs. 899.50 and Rs. 885.00 respectively. So far 3626 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1096.15 on 17-May-2013 and a 52 week low of Rs. 727.50 on 10-Oct-2012.

Last one week high and low of the scrip stood at Rs. 932.00 and Rs. 850.50 respectively. The current market cap of the company is Rs. 12479.53 crore.

The promoters holding in the company stood at 34.35% while Institutions and Non-Institutions held 45.34% and 19.52% respectively.

Apollo Hospitals Enterprise has entered into collaboration with Medtronic, Inc., the global leader in medical technology, to bring to market an innovative, affordable and portable hemodialysis system in India. This would help improve access to care for End Stage Renal Disease (ESRD) patients who need Renal Replacement Therapy (RRT). 

This collaboration will leverage a Medtronic-developed technology platform, supported by clinical insight from Apollo envisioning a cost reduction by 10-20 per cent for patients. At present, on an average a patient spends about Rs 1,200 to Rs 2,000 for a dialysis.

Medtronic intends to develop and manufacture key components of this hemodialysis system in India which will be ready for commercial launch in 2016.